Hartree Partners’s Johnson & Johnson JNJ Stock Holding History

Hartree Partners’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,771	Closed	-$345K	–	17
2017 Q1	$345K	Buy	+2,771	New	+$331K	0.38%	21

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hartree Partners's JNJ Position: Q2 2017 in Review

Hartree Partners sold out of Johnson & Johnson (JNJ) in Q2 2017, closing a stake of 2,771 shares — an estimated $345K sold.

Hartree Partners first reported a position in JNJ in Q1 2017 and held it in 1 quarter. The position peaked at $345K in Q1 2017. 2,349 funds tracked by Wall St. Rank hold JNJ as of Q2 2017.

Hartree Partners reported no remaining Johnson & Johnson position as of Q2 2017 after selling out during the quarter.
Hartree Partners sold 2,771 Johnson & Johnson shares in Q2 2017, an estimated $345K.
Hartree Partners first reported a position in Johnson & Johnson in Q1 2017 and held it in 1 quarter.
Hartree Partners's Johnson & Johnson position peaked at $345K in Q1 2017.
2,349 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2017.

Based on Hartree Partners's 13F filing for Q2 2017, filed 14 Aug 2017.